Clinical Trials Browser

Phase 4 × Hematologic Neoplasms × Imatinib Mesylate × Clear all

NCT03844360 2025-03-30

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Phase 4 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms